The NeuroBasic-PharmaPhenomics project is kindly sponsored by the following partners:

Ministery of Health, Welfare and Sport (VWS)

The NeuroBasic-PharmaPhenomics project is financed partly (50%) by a FES grant from the Dutch Ministry of Health, Welfare and Sport. FES stands for Fonds Economische Structuurversterking and is a Dutch fund which is funded by revenues from the natural gas income. FES was established in 1995 and aims at investments in infrastructure and the Dutch knowledge economy. NeuroBasic-PharmaPhenomics is part of the Drugs cluster. The Drugs cluster builds on the strong take off of TI Pharma and consolidates and aligns scattered initiatives, including selective continuity for research in three successful BSIK consortia: ‘NeuroBSIK’, ‘Virgo’ and ‘CDC’. The Drugs cluster offers the platform for the integrated approach necessary for the development of effective and safe new drugs to increase health. These activities are carried out with a simultaneous focus on economic benefits, to ensure wealth for the Dutch economy: jobs, (foreign) investments and increased entrepreneurial activity. The Drugs cluster will deliver partnerships, patents, publications and projects moving into clinical development. In addition the Drugs cluster will create a new generation of research professionals and further international expansion.

NeuroBasic-Pharmaphenomics is part of the LSH-FES portfolio: LSH

Logo LSH




VU University Amsterdam

The VU University has made the research facility ‘MouseHouse’ available to the NeuroBasic consortium for the duration of the project. The MouseHouse is an 800 square meter state-of-the-art reserach facility which includes screening facilities and R&D laboratories.